Working together to develop a screening platform to enhance the detection and management of Alzheimer’s disease.
PREDICTOM is an international across sector initiative to bring dementia diagnostics closer to the public through a customisable cognitive and biomarker screening platform.
Latest news
Launches Data Catalogue to Enhance Research Collaboration
The PREDICTOM project has launched a new data catalogue aimed at making its research datasets more accessible to the wider scientific community.
News
PREDICTOM Secures €21 Million Investment to Pioneer Early Alzheimer's Detection
In 2023, more than 7 million people are living with dementia in the European Union. This number is projected to double, reaching 14 million in 2050. This will create a huge burden on healthcare systems, both in terms of human and financial resources.
Our mission
PREDICTOM will identify scalable biosignatures for early and accurate diagnosis of Alzheimer’s disease and personalized preventive interventions.